breast
-
Health
New Research Challenges Longstanding Estimates of Overdiagnosis in Breast Cancer Screening
Breast cancer screening has long been viewed as a cornerstone of women’s preventative health, yet it remains a subject of…
Read More » -
Health
Reassessing the Scale of Breast Cancer Overdiagnosis Through a New Lens of Temporal Context and Clinical Evidence
For decades, the medical community has grappled with a fundamental dilemma in oncology: the phenomenon of overdiagnosis in breast cancer…
Read More » -
Health
AstraZeneca faces a significant setback as the breast cancer drug camizestrant fails to meet primary endpoints in a pivotal first-line clinical trial.
The pharmaceutical giant AstraZeneca confirmed on Friday that its novel oral endocrine therapy, camizestrant, failed to demonstrate a superior clinical…
Read More »
